AVENUE SOLUTIONS for JAZZ PHARMACEUTICALS, INC.
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Drug safety issues; Monitor drug pricing legislation; H.R. 5376, Build Back Better Act; Monitor Possible healthcare policies in upcoming reconciliation package including: making ACA tax credits/subsidies permanent, addressing Medicaid coverage gap, expanding home and community based services, prescription drug reform; Issues related to reauthorization of FDA user fee bills including accelerated approval; H.R. 5585, The Advanced Research Project Agency-Health (ARPA-H) Act; Issues related to the White House Cancer Moonshot initiative; Consolidated Appropriations Act, 2022 (PL 117-103)
| Lobbyist | Covered position, as disclosed |
|---|---|
| TRACY SPICER | — |
Copyright/Patent/Trademark CPT
S. 1435, Affordable Prescriptions for Patients Act of 2021
| Lobbyist | Covered position, as disclosed |
|---|---|
| TRACY SPICER | — |
Support LegiList
This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.